Published on in Vol 25 (2023)
Preprints (earlier versions) of this paper are
available at
https://preprints.jmir.org/preprint/43727, first published
.
1 Otsuka Pharmaceutical Development & Commercialization, Inc, Princeton, NJ, United States
2 Oxford PharmaGenesis Inc, Newtown, PA, United States